US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 20.650
  • +0.690+3.46%
Close Jul 8 16:00 ET
  • 20.650
  • 0.0000.00%
Post 16:56 ET
1.87BMarket Cap-7245P/E (TTM)

Rocket Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
8.33%67.38M
16.00%259.66M
-7.73%63.28M
11.87%65.43M
26.83%68.76M
46.12%62.19M
34.64%223.84M
56.46%68.58M
17.81%58.49M
59.22%54.21M
Selling and administrative expenses
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
40.70%58.77M
68.30%19.05M
50.67%15.11M
35.05%12.85M
-General and administrative expense
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
40.70%58.77M
68.30%19.05M
50.67%15.11M
35.05%12.85M
Research and development costs
-2.47%45.23M
12.55%186.34M
-16.57%41.74M
7.98%46.84M
24.25%51.38M
50.58%46.37M
31.95%165.57M
51.55%50.04M
9.49%43.38M
68.59%41.36M
Other operating expenses
----
----
----
----
----
----
50.00%-500K
----
----
----
Operating profit
-8.33%-67.38M
-16.00%-259.66M
7.73%-63.28M
-11.87%-65.43M
-26.83%-68.76M
-46.12%-62.19M
-34.64%-223.84M
-56.46%-68.58M
-17.81%-58.49M
-59.22%-54.21M
Net non-operating interest income expense
37.89%5.32M
610.30%14.06M
94.67%3.62M
382.24%3.53M
1,691.67%3.06M
1,023.21%3.86M
170.19%1.98M
549.03%1.86M
255.08%732K
59.75%-192K
Non-operating interest income
33.86%5.79M
309.85%15.94M
228.43%4.09M
195.57%4M
426.76%3.52M
594.54%4.33M
26.76%3.89M
46.47%1.25M
67.87%1.35M
33.53%669K
Non-operating interest expense
0.64%471K
-1.78%1.88M
176.55%470K
-24.48%469K
-45.64%468K
-55.04%468K
-67.58%1.91M
-148.58%-614K
-51.41%621K
-11.96%861K
Other net income (expense)
Income before tax
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
-15.24%-57.76M
-57.57%-54.4M
Income tax
Net income
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
-15.24%-57.76M
-57.57%-54.4M
Net income continuous Operations
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
-15.24%-57.76M
-57.57%-54.4M
Minority interest income
Net income attributable to the parent company
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
-15.24%-57.76M
-57.57%-54.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
-31.23%-221.86M
-50.80%-66.72M
-15.24%-57.76M
-57.57%-54.4M
Basic earnings per share
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
-22.10%-3.26
-28.99%-0.89
-10.13%-0.87
-50.91%-0.83
Diluted earnings per share
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
-22.10%-3.26
-28.99%-0.89
-10.13%-0.87
-50.91%-0.83
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 8.33%67.38M16.00%259.66M-7.73%63.28M11.87%65.43M26.83%68.76M46.12%62.19M34.64%223.84M56.46%68.58M17.81%58.49M59.22%54.21M
Selling and administrative expenses 39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M40.70%58.77M68.30%19.05M50.67%15.11M35.05%12.85M
-General and administrative expense 39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M40.70%58.77M68.30%19.05M50.67%15.11M35.05%12.85M
Research and development costs -2.47%45.23M12.55%186.34M-16.57%41.74M7.98%46.84M24.25%51.38M50.58%46.37M31.95%165.57M51.55%50.04M9.49%43.38M68.59%41.36M
Other operating expenses ------------------------50.00%-500K------------
Operating profit -8.33%-67.38M-16.00%-259.66M7.73%-63.28M-11.87%-65.43M-26.83%-68.76M-46.12%-62.19M-34.64%-223.84M-56.46%-68.58M-17.81%-58.49M-59.22%-54.21M
Net non-operating interest income expense 37.89%5.32M610.30%14.06M94.67%3.62M382.24%3.53M1,691.67%3.06M1,023.21%3.86M170.19%1.98M549.03%1.86M255.08%732K59.75%-192K
Non-operating interest income 33.86%5.79M309.85%15.94M228.43%4.09M195.57%4M426.76%3.52M594.54%4.33M26.76%3.89M46.47%1.25M67.87%1.35M33.53%669K
Non-operating interest expense 0.64%471K-1.78%1.88M176.55%470K-24.48%469K-45.64%468K-55.04%468K-67.58%1.91M-148.58%-614K-51.41%621K-11.96%861K
Other net income (expense)
Income before tax -6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M-15.24%-57.76M-57.57%-54.4M
Income tax
Net income -6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M-15.24%-57.76M-57.57%-54.4M
Net income continuous Operations -6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M-15.24%-57.76M-57.57%-54.4M
Minority interest income
Net income attributable to the parent company -6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M-15.24%-57.76M-57.57%-54.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M-31.23%-221.86M-50.80%-66.72M-15.24%-57.76M-57.57%-54.4M
Basic earnings per share 9.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73-22.10%-3.26-28.99%-0.89-10.13%-0.87-50.91%-0.83
Diluted earnings per share 9.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73-22.10%-3.26-28.99%-0.89-10.13%-0.87-50.91%-0.83
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg